Veteran international healthcare entrepreneur Semih Sen has been named the organization’s first chief business development officer.
Cleveland Clinic has tapped veteran international healthcare entrepreneur Semih Sen to be the its first chief business development officer as the organization continues to flex its ambitions globally.
In his role, Sen will be responsible for identifying and assessing new business opportunities, building partnerships and developing growth strategies.
He will also lead Cleveland Clinic Innovations, the commercialization arm of the organization, which is focused on bringing research IP into the market.
Sen will report directly to Cleveland Clinic CEO and President Tom Mihaljevic, who previously served as the CEO of Cleveland Clinic Abu Dhabi.
The health system has increasingly build up its presence internationally, with locations in Canada, Abu Dhabi and London.
Last year, the company added China to the list through a new international affiliation program called Cleveland Clinic Connected. The organization’s partnership with Luye Medical Group is meant to help export Cleveland Clinic’s expertise to the Shanghai New Hong Qiao International Medical Center.
“Partnerships and innovative growth strategies are more important than ever in today’s ever-changing healthcare landscape,” Mihaljevic said in a statement. “By focusing on long-term growth and development, we will further our mission of improving the lives of as many patients as possible.”
Sen is a native of Turkey with extensive experience in Europe and the Middle East, particularly in the United Arab Emirates. He is a founding partner of healthcare and life sciences VC firms Biolinka and healthcare investment advisory firm Casta Group.
His connection to Cleveland Clinic stems from when led development of an integrated healthcare network in his role as a director of Mubadala Investment Company’s healthcare unit, the organization’s partner for Cleveland Clinic Abu Dhabi.
Date: July 02, 2019